Zhenghang Wang

2.6k total citations · 1 hit paper
54 papers, 1.1k citations indexed

About

Zhenghang Wang is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhenghang Wang has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhenghang Wang's work include Colorectal Cancer Treatments and Studies (19 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Genetic factors in colorectal cancer (14 papers). Zhenghang Wang is often cited by papers focused on Colorectal Cancer Treatments and Studies (19 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Genetic factors in colorectal cancer (14 papers). Zhenghang Wang collaborates with scholars based in China, Ethiopia and United States. Zhenghang Wang's co-authors include Lin Shen, Jian Li, Zhi Peng, Xicheng Wang, Zhihao Lü, Xiaotian Zhang, Xi Jiao, Jifang Gong, Yuezong Bai and Lin Shen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Cell.

In The Last Decade

Zhenghang Wang

52 papers receiving 1.0k citations

Hit Papers

The loss of RNA N6-adenosine methyltransferase Mettl14 in... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Zhenghang Wang
Meagan Montesion United States
Rajan Dewar United States
Maria P. Wong Hong Kong
Aleksandra Dakic United States
Tricia R. Cottrell United States
David G. Coffey United States
Meagan Montesion United States
Zhenghang Wang
Citations per year, relative to Zhenghang Wang Zhenghang Wang (= 1×) peers Meagan Montesion

Countries citing papers authored by Zhenghang Wang

Since Specialization
Citations

This map shows the geographic impact of Zhenghang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenghang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenghang Wang more than expected).

Fields of papers citing papers by Zhenghang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenghang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenghang Wang. The network helps show where Zhenghang Wang may publish in the future.

Co-authorship network of co-authors of Zhenghang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenghang Wang. A scholar is included among the top collaborators of Zhenghang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenghang Wang. Zhenghang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Zhenghang, Xicheng Wang, Ming Cui, et al.. (2025). Toripalimab, bevacizumab, and irinotecan in dMMR/MSI locally advanced colorectal cancer: First-stage results from a phase 1b/2 trial. Cell Reports Medicine. 6(9). 102296–102296. 1 indexed citations
3.
Jia, Keren, Chen Yang, Yi Xie, et al.. (2024). Helicobacter pylori and immunotherapy for gastrointestinal cancer. The Innovation. 5(2). 100561–100561. 33 indexed citations
4.
Chen, Zifan, Yang Chen, Yu Sun, et al.. (2024). Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data. Signal Transduction and Targeted Therapy. 9(1). 222–222. 37 indexed citations
5.
Zhang, Zizhen, Shengde Liu, Zhenghang Wang, et al.. (2024). Influential upregulation of KCNE4: Propelling cancer associated fibroblasts-driven colorectal cancer progression. Cancer Cell International. 24(1). 103–103. 5 indexed citations
6.
Xu, Ting, Jian Li, Zhenghang Wang, et al.. (2023). Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer. Cancer Medicine. 12(9). 10473–10484. 9 indexed citations
7.
Wang, Zhenghang, et al.. (2023). A Machine Olfaction-Based Overheating Diagnosis Method for Electrical Equipment. IEEE Access. 11. 108804–108817. 4 indexed citations
8.
Liu, Jing, et al.. (2023). Multi-objective optimal peak load shaving strategy using coordinated scheduling of EVs and BESS with adoption of MORBHPSO. Journal of Energy Storage. 64. 107121–107121. 25 indexed citations
9.
Wu, Chunhua, Wenfei Li, Qi Zhang, et al.. (2023). Advances in KRAS mutation inhibition in metastatic colorectal cancer. 2(1). 4 indexed citations
10.
Wang, Yanni, Jianling Zou, Yun Li, et al.. (2022). Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers. Frontiers in Immunology. 13. 987568–987568. 24 indexed citations
11.
Wang, Zhenghang, Xue Zheng, Xicheng Wang, et al.. (2021). Genetic differences between lung metastases and liver metastases from left-sided microsatellite stable colorectal cancer: next generation sequencing and clinical implications. Annals of Translational Medicine. 9(12). 967–967. 9 indexed citations
12.
Chen, Chuanyuan, Yawei Zhang, Zhenghang Wang, et al.. (2021). The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth. Cancer Cell. 39(7). 945–957.e10. 201 indexed citations breakdown →
13.
Lü, Zhihao, Huan Chen, Xi Jiao, et al.. (2021). Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer. Genome Medicine. 13(1). 175–175. 12 indexed citations
14.
Zhang, Cheng, Zuhua Chen, Xiaoyi Chong, et al.. (2020). Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies. SHILAP Revista de lepidopterología. 10(8). e254–e254. 29 indexed citations
15.
Lü, Zhihao, Zhi Peng, Chang Liu, et al.. (2020). Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers. The Innovation. 1(2). 100041–100041. 54 indexed citations
16.
Xu, Ting, Jing Zhang, Changsong Qi, et al.. (2020). Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer. Frontiers in Oncology. 10. 568911–568911. 26 indexed citations
17.
Wang, Zhenghang, et al.. (2015). Secondary structure of expansion segment D1 in LSU rDNA from Arachnida and its phylogenetic application in Eriophyoid mites and in Acari. Experimental Parasitology. 159. 183–206. 2 indexed citations
18.
Zhao, Yae, Zhenghang Wang, Yang Xu, Liping Wu, & Hu Li. (2013). Secondary structure prediction for complete rDNA sequences (18S, 5.8S, and 28S rDNA) of Demodex folliculorum, and comparison of divergent domains structures across Acari. Experimental Parasitology. 135(2). 370–381. 19 indexed citations
19.
Zhao, Yae, et al.. (2012). Complete sequence analysis of 18S rDNA based on genomic DNA extraction from individual Demodex mites (Acari: Demodicidae). Experimental Parasitology. 131(1). 45–51. 28 indexed citations
20.
Zhao, Yae, Liping Wu, Li Hu, et al.. (2012). Sequencing for complete rDNA sequences (18S, ITS1, 5.8S, ITS2, and 28S rDNA) of Demodex and phylogenetic analysis of Acari based on 18S and 28S rDNA. Parasitology Research. 111(5). 2109–2114. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026